CDKN1A and hepatocellular carcinoma: Besides, it has been suggested that JMJD5 could inhibit the proliferation and cell cycle progression of hepatocellular carcinoma cells by regulating P21 (175, 176), and thus affecting the development of hepatocellular carcinoma (Figure 2).